Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pangramin Plus D. pteronyssinus in Local Allergic Rhinitis
NCT02123316Phase 2Completed
- Start
- Jan 2010
- Primary completion
- Apr 2014
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Pangramin Plus in allergic rhinitis (AR). Started Jan 2010; status: completed.
02
Drugs
Pangramin Plus
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT02123316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02123316.